AroCell
AroCell: Additional study shows use of TK1 concentration (Redeye)
2019-09-19 12:42
An additional study on thymidine kinase 1 concentration further demonstrates its use for breast cancer therapay response. The results presented are important for the company to spread awareness of the method.
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se